Veterinary Medicines

Cazitel Plus Tablets for Dogs

Authorised
  • Praziquantel
  • Febantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Cazitel Plus Tablets for Dogs
Cazitel Plus Tablets for Dogs
Active substance:
  • Praziquantel
  • Febantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 2 tablets.The strips are packed into cartons containing 2 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 4tablets.The strips are packed into cartons containing 4 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 6tablets,The strips are packed into cartons containing 6 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 8tablets.The strips are packed into cartons containing 8 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10tablets.The strips are packed into cartons containing 10 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12tablets.The strips are packed into cartons containing 12 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14tablets.The strips are packed into cartons containing 14 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 16tablets.The strips are packed into cartons containing 16 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 18tablets.The strips are packed into cartons containing 18 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20tablets.The strips are packed into cartons containing 20 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12 tablets. The strips are packed into cartons containing 24 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 28 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 6 tablets. The strips are packed into cartons containing 30 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 16 tablets. The strips are packed into cartons containing 32 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12 tablets. The strips are packed into cartons containing 36 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 40 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 42 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 4 tablets. The strips are packed into cartons containing 44 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 16 tablets. The strips are packed into cartons containing 48 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10 tablets. The strips are packed into cartons containing 50 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 4 tablets. The strips are packed into cartons containing 52 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 56 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 60 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 70 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 80 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 84 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 18 tablets. The strips are packed into cartons containing 90 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 98 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 100 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 8 tablets. The strips are packed into cartons containing 104 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 2 tablets. The strips are packed into cartons containing 106 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 120 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 140 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10 tablets. The strips are packed into cartons containing 150 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 180 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 200 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12 tablets. The strips are packed into cartons containing 204 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 2 tablets. The strips are packed into cartons containing 206 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10 tablets. The strips are packed into cartons containing 250 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 280 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 300 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 500 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 1000 tablets
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 1000 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 500 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 300 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 280 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 250 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 206 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 204 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 200 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 18 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 180 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 150 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 140 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 120 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 106 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 104 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 100 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 98 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 90 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 84 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 80 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 70 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 60 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 56 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 52 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 50 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 48 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 44 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 42 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 40 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 36 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 32 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 30 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 28 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 24 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 20 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 16 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 14 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 12 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 10 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 8 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 6 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 4 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 2 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 08749/3002
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0243/001
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Download

Combined File of all Documents

English (PDF)
Published on: 24/08/2025
Download

ie-puar-mr-iev0243001-cazitel-plus-tablets-for-dogs-en.pdf

English (PDF)
Published on: 25/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."